Monday, 25 Sep 2017

You are here

EULAR 2017 – Day 1 Highlights

The Annual EULAR Congress kicked off this afternoon in Madrid with a number of new sessions devoted to:

  • Criteria revision in lupus, Sjogren's syndrome and the antiphospholipid syndrome
  • The cancer – autoimmunity balance and the lessons learned from checkpoint inhibitors and the development of Immune Related Adverse Events (IRAEs)
  • Wearable technologies
  • New EULAR campaign “Don’t Delay, Connect Today”.  (Promoting early diagnosis and the role of early interventions (including drug and lifestyle interventions)
  • Progress in Spondyloarthritis Management
  • Comorbidities and Rheumatic disease

Posters start tomorrow.

For many it was a day of meeting up with international colleagues and avoiding the 100 degree heat. (Burger King's air conditioning seems to be very appealing)

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

22 September 2017 The RheumNow Week in Review

The RheumNow Week in Review discusses the past week's news, journal articles and highlights from RheumNow.com. This week's report discusses survey results on membranous nephritis and patient perceptions of steroids, nonadherence, celebrity arthritis and IgG4 treatment.

CDC: 40% of U.S Adults Claim to Have Arthritis

The CDC has reported its 2013 and 2014 prevalence statistics for arthritis and other chronic medical conditions affecting U.S. adults aged ≥18 years. Data is drawn from the ongoing Behavioral Risk Factor Surveillance System (BRFSS), a state-based, telephone survey of noninstitutionalized adults. Data herein is self-reported arthritis (OA, RA, Gout, FM) and is quantified by state and metropolitan areas.

15 September 2017 The RheumNow Week in Review

The RheumNow Week in Review discusses the past week's news, journal articles and highlights from RheumNow.com. This week's report discusses metabolic syndrome in lupus, bisphosphonate holidays, vasculitis and vascular inflammation, vaccination, and the repeated wonders of Vitamin D.

Why Rheumatologists Should Do Better Vaccinating this Flu Season

It is well known that influenza infection is more common in patients with rheumatologic diseases. Blumentals et al. showed that patients with rheumatoid arthritis are at increased risk for influenza regardless of DMARD/biologic use and may have a 2.75-fold increased incidence of related complications (https://buff.ly/2gYNTSz).

8 September 2017: The RheumNow Week in Review

The RheumNow Week in Review discusses the past week's news, journal articles and highlights from RheumNow.com. This week's report includes trends in MTX use and outcomes, fibromyalgia as an inflammatory disorder, drugs that stop psoriasis pruritus, drugs that don't cause TB, cardiovascular risk, and what Rheums think of ACR/EULAR criteria.